EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tracking Health Related Quality of Life From Diagnosis to Follow‐Up Among Australian Children With Acute Lymphoblastic Leukaemia

Clare Ghows iD, Clarissa E Schilstra iD, Karen McCleary, Nancy E Briggs iD, Rishi S Kotecha iD, Richard De Abreu Lourenco iD, Shanti Ramachandran, Ruelleyn Cockcroft, Rachel Conyers iD, Siobhan Cross, Luciano Dalla-Pozza, Peter Downie und 8 weitere

Pediatric Blood & Cancer · 2026

DOI: 10.1002/1545-5017.70539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Clare Ghows und 19 weiteren Autor:innen. Beteiligte Einrichtung: Behavioural Sciences Unit, School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, New South Wales, Australia. Hauptthemen laut MEDLINE: Quality of Life, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute lymphoblastic leukaemia (ALL) is one of the most treatable forms of paediatric cancer; however, there is a substantial burden of treatment‐related toxicities (TRTs). In addition, the long‐term changes in children's health‐related quality of life (HRQoL) due to toxic treatments are not well understood.

Aims

To describe parent‐reported HRQoL of children with ALL over a 5‐year period from diagnosis and identify risk factors associated with parent reporting of low HRQoL in children.

Methods

Through a national longitudinal prospective study, we invited parents of children diagnosed with ALL within the last 100 days to report the HRQoL impacts on their child over time using the PedsQL Cancer Module. Mixed models were used to identify predictors of HRQoL.

Results

In total, 190 parents participated at one or more time points (representing children with a mean age of 6.2 years). Parents reported clinically meaningful reductions in their child's HRQoL throughout ALL treatment: Within the first 6 months of diagnosis, 59.2% of parents reported that their child had reduced HRQoL and 47.6% did at 54 months. Procedural anxiety and cognitive dysfunction were key contributors to HRQoL through and beyond treatment. Age at diagnosis, sex and rurality were associated with HRQoL.

Conclusion

Almost half of parents reported that their children experienced poor HRQoL during and after treatment. Procedural anxiety and cognitive dysfunction were key contributors to HRQoL that did not reduce with time, demonstrating the need for comprehensive assessment of children's HRQoL to support access to psychosocial supportive care needs and improve overall HRQoL into survivorship years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifePrecursor Cell Lymphoblastic Leukemia-LymphomaHumansFemaleMaleChildChild, PreschoolFollow-Up StudiesProspective StudiesAustraliaAdolescentLongitudinal StudiesInfantParentsPrognosis

Stichwörter der Autor:innen

health‐related quality of lifepaediatric ALLpaediatric oncologypsychosocial

Autor:innen und Institutionen

  • Behavioural Sciences Unit, School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, New South Wales, Australia.
  • Minderoo Children's Comprehensive Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia.
  • Stats Central, Mark Wainwright Analytical Centre, UNSW Sydney, Kensington, New South Wales, Australia.
  • Department of Clinical Haematology, Oncology, Blood and Marrow Transplantation, Perth Children's Hospital, Nedlands, Western Australia, Australia.
  • Leukaemia Translational Research Laboratory, WA Kids Cancer Centre, The Kids Research Institute Australia, University of Western Australia, Perth, Western Australia, Australia.
  • Curtin Medical School, Curtin University, Perth, Western Australia, Australia.

ORCID-Profile: Clare Ghows, Clarissa E Schilstra, Nancy E Briggs, Rishi S Kotecha, Richard De Abreu Lourenco, Rachel Conyers, Claire E Wakefield, Toby Trahair, Marion K Mateos, Joanna E Fardell

Zitieren

APA

Ghows, C., Schilstra, C. E., McCleary, K., Briggs, N. E., Kotecha, R. S., Lourenco, R. A., Ramachandran, S., Cockcroft, R., Conyers, R., Cross, S., Dalla-Pozza, L., Downie, P., Revesz, T., Osborn, M., Alvaro, F., Wakefield, C. E., Marshall, G. M., Trahair, T., Mateos, M. K., & Fardell, J. E. (2026). Tracking Health Related Quality of Life From Diagnosis to Follow‐Up Among Australian Children With Acute Lymphoblastic Leukaemia. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70539

Vancouver

Ghows C, Schilstra CE, McCleary K, Briggs NE, Kotecha RS, Lourenco RA, et al. Tracking Health Related Quality of Life From Diagnosis to Follow‐Up Among Australian Children With Acute Lymphoblastic Leukaemia. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70539

BibTeX
@article{Ghows2026,
  author = {Ghows, Clare and Schilstra, Clarissa E and McCleary, Karen and Briggs, Nancy E and Kotecha, Rishi S and Lourenco, Richard De Abreu and Ramachandran, Shanti and Cockcroft, Ruelleyn and Conyers, Rachel and Cross, Siobhan and Dalla-Pozza, Luciano and Downie, Peter and Revesz, Tamas and Osborn, Michael and Alvaro, Frank and Wakefield, Claire E and Marshall, Glenn M and Trahair, Toby and Mateos, Marion K and Fardell, Joanna E},
  title = {Tracking Health Related Quality of Life From Diagnosis to Follow‐Up Among Australian Children With Acute Lymphoblastic Leukaemia},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/1545-5017.70539}
}
Kostenlos starten →